Cairo – Mubasher: Minapharm Pharmaceuticals recorded a 96.47% year-on-year (YoY) hike in its consolidated net profits attributable to the company's owners, logging EGP 255.63 million in the first half (H1) of 2021, compared to EGP 130.11 million.
The revenues increased to EGP 1.45 billion in the six-month period ended 30 June from EGP 1.06 billion in the corresponding period in 2020, the company said in a bourse disclosure on Monday.
During the first quarter (Q1) of 2021, the company posted consolidated net profits after tax, including minority rights, worth EGP 121.9 million, compared to EGP 79.24 million in the year-ago period.
